Vijaya Knight

1.1k total citations
36 papers, 713 citations indexed

About

Vijaya Knight is a scholar working on Infectious Diseases, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vijaya Knight has authored 36 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vijaya Knight's work include SARS-CoV-2 and COVID-19 Research (10 papers), Immunodeficiency and Autoimmune Disorders (9 papers) and SARS-CoV-2 detection and testing (8 papers). Vijaya Knight is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Immunodeficiency and Autoimmune Disorders (9 papers) and SARS-CoV-2 detection and testing (8 papers). Vijaya Knight collaborates with scholars based in United States, Canada and Australia. Vijaya Knight's co-authors include Edward D. Chan, Jennifer R. Honda, Patricia Merkel, Kyle Annen, Thomas E. Morrison, Mary K. McCarthy, Jamil N. Kanji, Carmen Charlton, Ashley Bailey and Sean C. Taylor and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Vijaya Knight

32 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vijaya Knight United States 13 267 179 163 110 106 36 713
Gabriela Barcenas‐Morales United Kingdom 12 217 0.8× 386 2.2× 324 2.0× 38 0.3× 67 0.6× 22 653
Florence Deknuydt France 9 167 0.6× 564 3.2× 179 1.1× 47 0.4× 139 1.3× 11 922
Alessia Grassi Italy 12 80 0.3× 148 0.8× 107 0.7× 129 1.2× 188 1.8× 20 623
Lingadakai Ramachandra India 15 101 0.4× 206 1.2× 79 0.5× 24 0.2× 214 2.0× 30 717
Bishwa R. Sapkota United States 13 484 1.8× 133 0.7× 416 2.6× 95 0.9× 190 1.8× 24 951
Alfredo Cruz‐Lagunas Mexico 13 171 0.6× 228 1.3× 208 1.3× 31 0.3× 76 0.7× 27 538
Ih Jen Su Taiwan 19 289 1.1× 165 0.9× 323 2.0× 26 0.2× 237 2.2× 32 955
Direkrit Chiewchengchol Thailand 16 84 0.3× 217 1.2× 48 0.3× 99 0.9× 140 1.3× 30 481
Esra Adışen Türkiye 16 63 0.2× 196 1.1× 192 1.2× 81 0.7× 51 0.5× 73 711
Kentaro Nakashima Japan 14 155 0.6× 56 0.3× 216 1.3× 69 0.6× 199 1.9× 51 771

Countries citing papers authored by Vijaya Knight

Since Specialization
Citations

This map shows the geographic impact of Vijaya Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vijaya Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vijaya Knight more than expected).

Fields of papers citing papers by Vijaya Knight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vijaya Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vijaya Knight. The network helps show where Vijaya Knight may publish in the future.

Co-authorship network of co-authors of Vijaya Knight

This figure shows the co-authorship network connecting the top 25 collaborators of Vijaya Knight. A scholar is included among the top collaborators of Vijaya Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vijaya Knight. Vijaya Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Knight, Vijaya, Patricia Merkel, Molly M. Lamb, et al.. (2022). COVID-19 Serology Control Panel Using the Dried-Tube Specimen Method. American Journal of Tropical Medicine and Hygiene. 106(2). 562–565.
5.
Annen, Kyle, et al.. (2021). Presence and short‐term persistence of SARS‐CoV ‐2 neutralizing antibodies in COVID ‐19 convalescent plasma donors. Transfusion. 61(4). 1148–1159. 9 indexed citations
6.
7.
Dawson, Erica D., et al.. (2021). Multiplexed, microscale, microarray-based serological assay for antibodies against all human-relevant coronaviruses. Journal of Virological Methods. 291. 114111–114111. 10 indexed citations
8.
Theel, Elitza S., Vijaya Knight, Kamran Kadkhoda, et al.. (2021). Interlaboratory Agreement of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serologic Assays in the Expedited College of American Pathologists Proficiency Testing Program. Archives of Pathology & Laboratory Medicine. 145(5). 536–542. 5 indexed citations
9.
Knight, Vijaya, et al.. (2021). An enzyme-linked immunospot assay to evaluate Pneumovax response when on intravenous immunoglobulin. Annals of Allergy Asthma & Immunology. 128(1). 61–67.e4. 3 indexed citations
10.
Schultz, Jonathan, Mary K. McCarthy, Katherine R. Sabourin, et al.. (2021). Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA. Journal of Clinical Microbiology. 59(6). 18 indexed citations
11.
Knight, Vijaya, Jennifer Heimall, Hey Chong, et al.. (2021). A Toolkit and Framework for Optimal Laboratory Evaluation of Individuals with Suspected Primary Immunodeficiency. The Journal of Allergy and Clinical Immunology In Practice. 9(9). 3293–3307.e6. 11 indexed citations
12.
Ataya, Ali, Vijaya Knight, Brenna Carey, et al.. (2021). The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review. Frontiers in Immunology. 12. 752856–752856. 41 indexed citations
13.
Wortmann, Saskia B., Johan L.K. Van Hove, Terry G. J. Derks, et al.. (2020). Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor. Blood. 136(9). 1033–1043. 93 indexed citations
14.
Knight, Vijaya, Thomas Long, Qing H. Meng, Michael A. Linden, & Daniel D. Rhoads. (2020). Variability in the Laboratory Measurement of Cytokines. Archives of Pathology & Laboratory Medicine. 144(10). 1230–1233. 19 indexed citations
15.
Wang, Meiqin, Matthew Strand, Bruce J. Lanser, et al.. (2020). Expression and activation of the steroidogenic enzyme CYP11A1 is associated with IL-13 production in T cells from peanut allergic children. PLoS ONE. 15(6). e0233563–e0233563. 11 indexed citations
16.
Merkel, Patricia, et al.. (2019). Functional Analysis of Anti-cytokine Autoantibodies Using Flow Cytometry. Frontiers in Immunology. 10. 1517–1517. 17 indexed citations
17.
Knight, Vijaya, Patricia Merkel, & Michael O’Sullivan. (2016). Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation. Antibodies. 5(1). 3–3. 23 indexed citations
19.
Clark, Sarah E., Rebecca L. Schmidt, A. M. Jamieson, et al.. (2016). Bacterial Manipulation of NK Cell Regulatory Activity Increases Susceptibility to Listeria monocytogenes Infection. PLoS Pathogens. 12(6). e1005708–e1005708. 47 indexed citations
20.
Hines, Stella E., et al.. (2015). Cross‐Sectional Study of Respiratory Symptoms, Spirometry, and Immunologic Sensitivity in Epoxy Resin Workers. Clinical and Translational Science. 8(6). 722–728. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026